U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.
- Amazon.com, Inc. (NASDAQ:AMZN) shares tumbled 13.6% to $95.88 in pre-market trading. Amazon.com reported upbeat earnings for its third quarter, while sales missed estimates. The company also issued weak sales forecast for the fourth quarter.
- Zai Lab Limited (NASDAQ:ZLAB) dropped 12.5% to $22.50 in pre-market trading. Zai Lab is expected to announce Q3 financial results on November 9, 2022.
- Edwards Lifesciences Corporation (NYSE:EW) shares declined 10% to $77.69 in pre-market trading after the company reported worse-than-expected Q3 EPS and sales results. The company also lowered its FY22 EPS guidance below analyst estimates.
- XPeng Inc. (NYSE:XPEV) dipped 9.2% to $6.68 in pre-market trading after dropping 10% on Thursday. Cities in China ranging from Wuhan in central China to Xining in the north-west are doubling down on COVID-19 curbs, reported Reuters.
- Li Auto Inc. (NASDAQ:LI) dropped 8.6% to $13.69 in pre-market trading after declining 8% on Thursday. Cities in China ranging from Wuhan in central China to Xining in the north-west are doubling down on COVID-19 curbs, reported Reuters.
- NatWest Group plc (NYSE:NWG) shares declined 8.4% to $5.24 in pre-market trading after the company posted downbeat Q3 profit.
- First Solar, Inc. (NASDAQ:FSLR) shares fell 7.6% to $121.25 in pre-market trading after the company reported worse-than-expected Q3 EPS and sales results. The company also cut its FY22 gross profit guidance.
- Autohome Inc (NASDAQ:ATHM) fell 7% to $26.16 in pre-market trading.
- Monolithic Power Systems, Inc. (NASDAQ:MPWR) fell 6.8% to $306.97 in pre-market trading after the company issued Q4 sales guidance below analyst estimates.
- Bilibili Inc. (NASDAQ:BILI) dropped 6.6% to $8.89 in pre-market trading. Citigroup downgraded Bilibili from Buy to Neutral and lowered the price target from $38 to $12.
- L3Harris Technologies, Inc (NYSE:LHX) declined 5.9% to $238.00 in pre-market trading after the company reported worse-than-expected Q3 EPS and sales results. The company also issued FY22 EPS and sales guidance below analyst estimates. Raymond James downgraded L3Harris Technologies from Outperform to Market Perform.
